Back to search

Article

A Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2): study protocol

2025-11-22

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Germline cancer genetic testing has become a standard evidence-based practice, with established risk reduction and cancer screening guidelines for genetic carriers. There are also targeted treatments for some genetic carriers with cancers such as breast and ovarian cancer. Yet, many at-risk patients do not have access to genetic services, leaving many genetic carriers uniden...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3c3814a4-ac33-5d3f-a0f2-917089688d36
DOI
10.1101/2025.11.19.25340515
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer (eREACH2): study protocolDOI 10.1101/2025.11.19.25340515
Select a neighboring publication to make it the new centre.